PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Mauri, Laura
TI  - Drug-Eluting Stents Prevent Death, MI, and Revascularization in Patients with Diabetes
DP  - 2009 Feb 01
TA  - MD Conference Express
PG  - 15--16
VI  - 8
IP  - 8
4099  - http://mdc.sagepub.com/content/8/8/15.short
4100  - http://mdc.sagepub.com/content/8/8/15.full
AB  - For patients with diabetes who undergo percutaneous coronary intervention (PCI), drug-eluting stents (DES) reduce the risk of mortality, acute myocardial infarction (MI), and repeat revascularization compared with bare-metal stents (BMS). These 3-year findings from the Massachusetts Data Analysis Center Registry (Mass-DAC), which requires mandatory reporting and follow-up, reflect achievable treatment outcomes in the real-world clinical setting, researchers reported.